Compare AU
Compare DFND vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are DFND and DRUG. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
DFND | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 37 | 63 |
Median incremental investment | $1,015.00 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,550.38 | $1,875.72 |
Average age group | > 35 | 26 - 35 |
Key Summary
DFND | DRUG | |
|---|---|---|
Strategy | DFND.AX was created on 2024-09-10 by VanEck. The fund's investment portfolio concentrates primarily on theme equity. DFND.AX gives investors exposure to a portfolio of listed global companies involved in the military or defence industries. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | VanEck Global Defence ETF (100 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0 % | 0.57 % |
Key Summary
DFND | DRUG | |
|---|---|---|
Issuer | VanEck | BetaShares |
Tracking index | MarketVector Global Defence Industry (AUD) Index - AUD - Benchmark TR Net | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0 % | 0.57 % |
Price | $23.14 | $8.12 |
Size | $20.813 million | $191.120 million |
10Y return | N/A | N/A |
Annual dividend/ distribution yield (5Y) | - % | 1.90 % |
Market | ASX | ASX |
First listed date | 11/09/2024 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DFND | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 37 | 63 |
Median incremental investment | $1,015.00 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,550.38 | $1,875.72 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
DFND | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DFND | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |